Stocks
Friday, 20 Feb 2026
NOVA PHARMA SOLUTIONS BERHAD
- Board : Warrants
- Stock Code : 03006
- 52 Week High : 0.215
- 52 Week Low : 0.135
| Open | High | Low | Last | Chg | Chg % | Vol ('00) | Buy/Vol ('00) | Sell/Vol ('00) |
| 0.000 | 0.000 | 0.000 | 0.135 | 0.000 | 0.00 | 0 | .000 / 0 | .000 / 0 |
Log in to save your chart settings and more
- View Chart:
- 3 months
- 1 day
Financial Results
| Date Announced |
Financial Year End |
QTR | Period End | Revenue RM (,000) |
P&L RM (,000) |
EPS |
| 09 Feb 2026 | 30 Jun 2026 | 2 | 31 Dec 2025 | 12,459 | 3,023 | 2.03 |
| 25 Aug 2025 | 31 Dec 2025 | 2 | 30 Jun 2025 | 7,357 | 2,969 | 1.99 |
| 26 Aug 2024 | 31 Dec 2024 | 2 | 30 Jun 2024 | 5,119 | 1,924 | 1.29 |
| 22 Feb 2024 | 31 Dec 2023 | 4 | 31 Dec 2023 | 4,994 | 1,834 | 1.23 |
| 15 Aug 2023 | 31 Dec 2023 | 2 | 30 Jun 2023 | 5,385 | 2,107 | 1.41 |
NOVA PHARMA SOLUTIONS BERHAD
The principal activities of the Company consist of provision technical documentation validation and project execution in the pharmaceutical and biotechnology industries.
Address
9A JALAN MEDAN TUANKU,MEDAN TUANKU,KUALA LUMPUR, FEDERAL TERRITORY
Malaysia
Contact
(60)
(60)
| 31 Dec 2020RM'000 | 31 Dec 2021RM'000 | 31 Dec 2022RM'000 | |
| Income Statement | |||
| Net Turnover/Net Sales | 4,235 | 6,280 | 7,245 |
| EBITDA | -587 | 569 | 1,370 |
| EBIT | -811 | 408 | 1,205 |
| Net Profit | -649 | 482 | 1,186 |
| BALANCE SHEET | |||
| Intangibles | - | - | - |
| Fixed Assets | 183 | 94 | 169 |
| Long Term Investment | - | - | - |
| Stocks/Inventories | - | - | - |
| Cash | 250 | 2,567 | 1,746 |
| Current Liabilities | 1,896 | 2,862 | 2,612 |
| Long Term Debt | - | - | - |
| Provisions | - | - | - |
| Minorities | - | - | - |
| Total Shareholders Equity | 9,863 | 10,346 | 11,159 |
| KEY RATIOS | |||
| Operating Margin(%) | -16.74 | 8.93 | 20.4 |
| Return on Equity Capital(%) | -6.35 | 4.77 | 11.03 |
| Net Profit Margin | -15.32 | 7.67 | 16.37 |
| Current Ratio | 6.07 | 4.57 | 5.19 |
| Debt to Capital at Book | 0.01 | 0 | 0.01 |
World'Vest Base, Inc.© 2026
Under no circumstances this document is to be used or considered as an offer to sell, or a solicitation of any offer to buy, any security. While information contained herein has been obtained from sources believed to be reliable, WVB does not represent that it is accurate or complete and it should not be relied upon as such.
1335, North Dearborn Parkway, Chicago, IL 60610
Tel: +1-312-922-4201 | Fax: 1-312-922-3277 | Email: inforequest@wvb.com
Financial Data Owned and Supplied by World'vest Base Inc. Copyright , All Rights Reserved.
| Company | Date announced |
To those registered by |
To be paid on |
Dividend | Ex-Dates |
| 12 Dec 2018 | 28 Dec 2018 | 18 Jan 2019 | 1st Interim Single Tier 0.4sen | 26 Dec 2018 | |
| 24 Dec 2019 | 03 Jan 2020 | 17 Jan 2020 | 1st Interim Single Tier 0.2sen TE | 02 Jan 2020 | |
| 28 Jun 2019 | 16 Jul 2019 | 08 Aug 2019 | Final Single Tier 0.2sen | 15 Jul 2019 | |
| 23 Aug 2022 | 02 Sep 2022 | 15 Sep 2022 | Single-tier Interim Dividend of 0.25 sen per share tax exempt for the financial year ending 31 December 2022 | 01 Sep 2022 | |
| 21 Aug 2023 | 30 Aug 2023 | 15 Sep 2023 | Single-tier Interim Dividend of 0.5 sen per share tax exempt for the financial year ending 31 December 2023 | 29 Aug 2023 | |
| 25 Nov 2024 | 12 Dec 2024 | 27 Dec 2024 | NOVA PHARMA SOLUTIONS BERHAD announced a quarterly dividend of RM 0.0060 per share. The dividend is payable on 27-Dec-2024, while the ex-date will be on 11-Dec-2024. This is higher than the previous dividend of RM 0.0050 per share, with ex-date of 29-Aug- | 11 Dec 2024 | |
| 21 Nov 2025 | 01 Dec 2025 | 26 Dec 2025 | NOVA PHARMA SOLUTIONS BERHAD announced a quarterly dividend of RM 0.0800 per share. The dividend is payable on 26-Dec-2025, while the ex-date will be on 28-Nov-2025. This is higher than the previous dividend of RM 0.0060 per share, with ex-date of 11-Dec-2024 and paid to the shareholders on 27-Dec-2024. | 28 Nov 2025 |
